BSE Sensex 30 Stocks Regulatory Filings — May 11, 2026

11-05-2026

The Board of Directors of Satin Creditcare Network Limited approved the Audited Standalone Financial Results for the quarter and year ended March 31, 2026, with an unmodified auditor's opinion from J C Bhalla & Co. Total revenue from operations for FY26 grew 19.8% YoY to ₹2,82,243.68 L, while net profit after tax increased 39.5% YoY to ₹30,208.07 L; Q4 FY26 revenue surged 46.2% YoY to ₹81,157.42 L and PAT rose over 333% YoY to ₹13,694.81 L. Total assets expanded 21.2% to ₹13,19,627.91 L, driven by higher cash and loans.

• · Auditor's report issued with unmodified opinion.
• · Board meeting held on May 11, 2026, from 2:30 p.m. to 4:30 p.m. IST.
• · Trading window closed until 48 hours after publication.
• · EPS Basic FY26: ₹27.46 (vs ₹19.69 FY25); Diluted same.
• · Interest income FY26: ₹2,21,437.81 L (up from ₹2,08,868.93 L).

11-05-2026

HCL Technologies Limited is seeking shareholder approval via postal ballot notice dated May 8, 2026, for the appointment of Ms. Kimsuka Narsimhan (DIN: 02102783) as a Non-Executive Independent Director for a term of five years from April 20, 2026, to April 19, 2031. She was appointed as an Additional Director by the Board on April 20, 2026, and brings over 35 years of experience in finance, risk management, strategic leadership, and ESG from roles at PepsiCo, Unilever, and Kimberly-Clark, along with current directorships at Bharti Airtel and Meesho. The remote e-voting period runs from May 12, 2026 (9:00 a.m. IST) to June 10, 2026 (5:00 p.m. IST), with a cut-off date of May 6, 2026.

• · Cut-off date for e-voting eligibility: May 6, 2026
• · Board meeting for initial appointment: April 20-21, 2026
• · Ms. Narsimhan co-opted to Audit Committee and Risk Management Committee effective April 20, 2026
• · DIN: 02102783
• · No relationships with other directors or KMPs
• · Entitled to sitting fees and profit-related commission within 1% of net profits limit for non-executive directors

11-05-2026

Maruti Suzuki India Limited informed stock exchanges about an update on an ongoing matter before the Competition Commission of India (CCI), previously disclosed on April 24, 2026. The matter was listed for hearing on May 11, 2026, but CCI sought an adjournment, and it has now been rescheduled to May 25, 2026, for arguments on behalf of CCI. No further details on the nature or outcome of the matter were provided.

• · Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
• · Registered office: 1, Nelson Mandela Road, Vasant Kunj, New Delhi - 110070

11-05-2026

State Bank of India announced the withdrawal of nomination by Shri Dharmendra Singh Shekhawat for election as a Director to the Central Board under Section 19(c) of the State Bank of India Act, 1955. His name will be excluded from the list of candidates, with the remaining validly nominated candidates to be voted on at the General Meeting of Shareholders on May 15, 2026, at 03:00 PM via Video Conferencing/Other Audio Visual Means. This follows prior notifications dated April 27, 2026, and May 4, 2026.

• · BSE Scrip Code: 500112
• · NSE Scrip Code: SBIN
• · Reference letters: CC/S&B/AND/2026-27/79 dated 27.04.2026 and CC/S&B/AND/2026-27/98 dated 04.05.2026
• · Nominated under Section 19A of State Bank of India Act, 1955 read with RBI (Commercial Banks - Governance) Directions, 2025

11-05-2026

Sun Pharma Advanced Research Company Ltd (SPARC) has scheduled a Board of Directors meeting on May 18, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The trading window for dealing in the company's shares remains closed for Directors, KMPs, Designated Employees, and Connected Persons from April 01, 2026, until 48 hours after the financial results are declared and submitted to stock exchanges. This intimation complies with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

• · Scrip Symbol: SPARC
• · Scrip Code: 532872
• · Trading Window closure intimated vide letter dated March 26, 2026

11-05-2026

Sun Pharmaceutical Industries Limited has scheduled a Board of Directors meeting on May 22, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026, and to recommend a final dividend, if any, for FY 2025-26 for shareholder approval at the upcoming Annual General Meeting. The trading window remains closed from April 1, 2026, until May 24, 2026, as previously intimated.

• · Trading Window closed from Wednesday, 01 April 2026, until Sunday, 24 May 2026.
• · NSE Code: SUNPHARMA; BSE Stock Code: 524715.
• · CIN: L24230GJ1993PLC019050.
• · ICSI Membership No. of Company Secretary: A23983.

11-05-2026

Adani Ports and Special Economic Zone Limited disclosed changes in senior management personnel under Regulation 30 of SEBI Listing Regulations: Mr. Pranav Choudhary ceased as CEO – Ports effective May 31, 2026, to pursue career opportunities outside the Adani Group. Mr. Niraj Bansal was appointed as CEO – Ports effective June 1, 2026. Mr. Bansal brings over 27 years of experience, including as a former IRS officer, Deputy Chairman and Chairman-in-charge of Jawaharlal Nehru Port Trust (JNPT) from 2014-2019, and recent roles within the Adani Group at Hazira Port and New Port Project Development, Maharashtra.

• · Mr. Niraj Bansal took voluntary retirement as Commissioner of Income Tax prior to JNPT role.
• · During Mr. Bansal's JNPT tenure (2014-2019), the port achieved record performance including highest cargo since inception.
• · Mr. Bansal joined Adani Group in October 2022.
• · Disclosure available on company website www.adaniports.com.

11-05-2026

Infosys Limited received no-objection letters from BSE Limited and National Stock Exchange of India Limited, both dated May 11, 2026, approving the re-classification of Mr. Shreyas Shibulal and Ms. Bhairavi Madhusudhan Shibulal from 'Promoter and Promoter Group' to 'Public' category under Regulation 31A of SEBI (LODR) Regulations, 2015. This follows prior disclosures on April 30, 2026, and May 1, 2026, and an application dated May 1, 2026. The letters are enclosed with the filing and will be available on the company's website www.infosys.com.

• · NSE Reference: NSE/LIST/COMP/INFY/587/2026-2027
• · Company Secretary Membership No: A21918

11-05-2026

Larsen & Toubro Limited has confirmed the upload of the transcript for its Q4/FY26 Earnings Call, held on May 5, 2026, to its investor website in compliance with SEBI (LODR) Regulations. The company notified BSE Limited and National Stock Exchange of India Limited to host the transcript on their platforms. No financial metrics or performance details are disclosed in this procedural update.

• · Transcript URL: https://investors.larsentoubro.com/Transcripts-Archives.aspx
• · BSE Stock Code: 500510
• · NSE Stock Code: LT
• · Filing reference: SEC/2026 May 11, 2026